Impact of sputum smear-negative (AFB) TB results on clinical outcomes in TB/HIV co-infected patients at a teaching hospital in Ghana

Autor: Mudd, Jeremy, Jaramillo, Livia, Kwara, Esther, Dale, Brandon, Kwartent, Ernest, Baddoo, Nyonuku Baddoo, Forson, Audrey, Lartey, Margaret, Kwara, Awewura

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ff16c14c2fc7388a6ab4fc63294c5a48

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants.

Autor: Espy N; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Han X; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Grant S; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Kwara E; Division of Infectious Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Lakshminarayanan B; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Stirewalt M; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Seaton KE; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Tomaras GD; Department of Surgery, Duke University, Durham, North Carolina, United States of America., Goecker E; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., McElrath J; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America., Andriesen J; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Huang Y; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America., Walsh SR; Division of Infectious Diseases, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Hural J; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2023 Jun 08; Vol. 3 (6), pp. e0002037. Date of Electronic Publication: 2023 Jun 08 (Print Publication: 2023).

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.

Autor: Oganezova K; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Fontana-Martinez EJ; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Gothing JA; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Pandit A; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kwara E; Morehouse School of Medicine, Atlanta, Georgia, USA., Yanosick K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Dragavon J; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA., Goecker EA; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA., Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Espy N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Tomaka F; Janssen Pharmaceutical Research and Development, Titusville, New Jersey, USA., Lavreys L; Janssen Vaccines & Prevention, B.V., Leiden, The Netherlands., Allen M; National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA., D'Souza P; National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA., Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Coombs RW; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Dolin R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2020 Dec 15; Vol. 8 (1), pp. ofaa606. Date of Electronic Publication: 2020 Dec 15 (Print Publication: 2021).